1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, June 2016 (p4)

Biological Therapy Analysis & Statistics, June 2016 (p4)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

91-120 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World, United States
Multiple Sclerosis - Pipeline Review, H1 2016

Multiple Sclerosis - Pipeline Review, H1 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape. ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Nucleus Replacement - Medical Devices Pipeline Assessment, 2016

Nucleus Replacement - Medical Devices Pipeline Assessment, 2016

  • $ 2 500
  • Industry report
  • June 2016
  • by Global Data

Nucleus Replacement - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview ...

  • Industries : Biological Therapy, Medical Device
  • Countries : United States
Follicular Lymphoma Global Clinical Trials Review, H1, 2016

Follicular Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Follicular Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Follicula ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World, United States
Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : United States, World
Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World, United States
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016" ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of Hairy Cell ...

  • Industries : Cancer, Pathology
  • Countries : World
Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : United States, World
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Chronic Disease, Pathology, Therapy
  • Countries : World
Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
B-Cell Leukemia Global Clinical Trials Review, H1, 2016

B-Cell Leukemia Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

B-Cell Leukemia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Leukemia clinical ...

  • Industries : Cancer, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World, United States
Amyloidosis Global Clinical Trials Review, H1, 2016

Amyloidosis Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Amyloidosis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Therapy, Healthcare
  • Countries : World
Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016

Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Epidermolysis Bullosa Global Clinical Trials Review, H1, 2016" provides an overview of Epidermolysis ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : World
Dilated Cardiomyopathy - Pipeline Review, H2 2016

Dilated Cardiomyopathy - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H2 2016’, provides an overview of the Dilated Cardiomyopathy pipeline ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : United States
Vasculitis - Pipeline Review, H2 2016

Vasculitis - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Vasculitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Vasculitis - Pipeline Review, H2 2016’, provides an overview of the Vasculitis pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology
  • Countries : Europe, World, United States
House Dust Mite Allergy - Pipeline Review, H2 2016

House Dust Mite Allergy - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

House Dust Mite Allergy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘House Dust Mite Allergy - Pipeline Review, H2 2016’, provides an overview of the House Dust Mite Allergy pipeline ...

  • Industries : Therapy, Chronic Disease, Pathology
  • Countries : World, Japan, United States, Europe, North America
Degenerative Disc Disease - Pipeline Review, H2 2016

Degenerative Disc Disease - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Degenerative Disc Disease - Pipeline Review, H2 2016’, provides an overview of the Degenerative Disc Disease ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World
Sepsis - Pipeline Review, H2 2016

Sepsis - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Sepsis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2016’, provides an overview of the Sepsis pipeline landscape. The report provides comprehensive information ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Acute Lung Injury - Pipeline Review, H1 2016

Acute Lung Injury - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Lung Injury - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Lung Injury - Pipeline Review, H1 2016’, provides an overview of the Acute Lung Injury pipeline landscape. The ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Non-Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape. ...

  • Industries : Cancer, Pathology
  • Countries : United States
Fanconi Anemia - Pipeline Review, H1 2016

Fanconi Anemia - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fanconi Anemia - Pipeline Review, H1 2016’, provides an overview of the Fanconi Anemia pipeline landscape. The report provides ...

  • Industries : Pathology
  • Countries : United States
Canavan Disease - Pipeline Review, H1 2016

Canavan Disease - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Canavan Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Canavan Disease - Pipeline Review, H1 2016’, provides an overview of the Canavan Disease pipeline landscape. The report ...

  • Industries : Mental Health, Pathology, Biological Therapy
  • Countries : United States
Aplastic Anemia - Pipeline Review, H1 2016

Aplastic Anemia - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Aplastic Anemia - Pipeline Review, H1 2016’, provides an overview of the Aplastic Anemia pipeline landscape. The report ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Hepatitis B - Pipeline Review, H1 2016

Hepatitis B - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2016’, provides an overview of the Hepatitis B pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic ...

  • Industries : Cancer, Pathology
  • Countries : United States
Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016

  • $ 1 950
  • Industry report
  • July 2016
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Technology and Pipeline Analysis, 2016”, report provides comprehensive insights about pipeline drugs across this indication. Key objective ...

  • Industries : Biological Therapy
T-Cell Immunotherapy for Cancer -  Pipeline Analysis

T-Cell Immunotherapy for Cancer - Pipeline Analysis

  • $ 1 500
  • Industry report
  • August 2016
  • by RNCOS

Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012, the incidence of cancer is expected to increase from 14 Million in 2012 to approximately 21 Million by 2030. Although conventional ...

  • Industries : Biological Therapy
  • Countries : World
Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • July 2016
  • by Global Markets Direct

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review, 2016’, provides an overview of the Alnylam ...

  • Industries : Pharmaceutical, Research and Development, Pathology
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.